Deep Insight

About The Fund

Deep Insight is an investment fund based in Israel, focusing on a wide range of industries within the deep tech sector. They are the first dedicated fund in Israel that is stage agnostic, seeking out deep tech opportunities in all stages of a company's lifecycle. The fund invests in diverse fields including semiconductors, bio convergence, future robotics, advanced materials, photonics, and quantum technologies. Deep Insight's investment philosophy is propelled by the belief that new problems cannot be solved with old thinking, a sentiment echoed by the quote from Albert Einstein on their website. The firm has set its investment range between $100,000 as a minimum and $5,000,000 as a maximum, with a sweet spot of around $1,500,000, primarily focusing on Seed and Series A funding stages. Their assets under management amount to $922,000. Deep Insight's team is comprised of experienced professionals with varied backgrounds ranging from venture capital and deep tech investments to computer science, robotics, law, and public investments. The company’s portfolio includes TriEye, Rapid, Ramon.Space, Aviv Scientific, Biond Biologics, Addionics, Bionaut, MediWound, Alpha Tau Medical, Magnus Metal, Exsilio, and GreenEye, showcasing their commitment to developing technologies that address crucial challenges in safety, medical care, computing, aging, battery technology, remote-controlled micro-robots for CNS disorders, cancer treatment methods, the casting industry, gene therapy, and precision agriculture, respectively. Deep Insight is deeply rooted in the Israeli tech ecosystem, an environment renowned for its rich proliferation of deep tech innovation. They are open to exploring collaborations with science fiction companies, indicating their readiness to invest in avant-garde and potentially transformative technological advances.